Evidence map›Paper›PMID 34118930›Full record

ArticleAnnals of clinical microbiology and antimicrobials2021

Antimicrobial susceptibility of gram-positive and gram-negative bacteria: a 5-year retrospective analysis at a multi-hospital healthcare system in Saudi Arabia.

Saad Alhumaid, Abbas Al Mutair, Zainab Al Alawi, Ahmad J Alzahrani, Mansour Tobaiqy, Ahmed M Alresasi, Ibrahim Bu-Shehab, Issa Al-Hadary, Naif Alhmeed, Mossa Alismail and 5 more

Open access · goldAbstract read
In one paragraph

Article in Annals of clinical microbiology and antimicrobials, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it, 71 citations in OpenAlex.

  1. Antibiotic Resistance during COVID-19: A Systematic Review.International journal of environmental research and public health · 2022
    Pooled it
  2. Article
  3. Multidrug Resistance andPathogens (Basel, Switzerland) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Solvent Fractionation ofInternational journal of molecular sciences · 2025
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 10 institutions in 3 countries.

Saad AlhumaidAdministration of Pharmaceutical Care, Alahsa Health Cluster, Ministry of Health, Rashdiah Street, P. O. Box 12944, Alahsa, 31982, Saudi Arabia. saalhumaid@moh.gov.sa.ORCID http://orcid.org/0000-0003-4552-4513
Abbas Al MutairResearch Center, Almoosa Specialist Hospital, Alahsa, Saudi Arabia.ORCID http://orcid.org/0000-0002-9471-2767
Zainab Al AlawiDepartment of Pediatrics, College of Medicine, King Faisal University, Alahsa, Saudi Arabia.
Ahmad J AlzahraniCollege of Medicine, Al-Imam Mohammed Ibn Saud Islamic University, Riyadh, Saudi Arabia.
Mansour TobaiqyDepartment of Pharmacology, College of Medicine, University of Jeddah, Jeddah, Saudi Arabia.
Ahmed M AlresasiAdministration of Pharmaceutical Care, Alahsa Health Cluster, Ministry of Health, Rashdiah Street, P. O. Box 12944, Alahsa, 31982, Saudi Arabia.
Ibrahim Bu-ShehabAdministration of Pharmaceutical Care, Alahsa Health Cluster, Ministry of Health, Rashdiah Street, P. O. Box 12944, Alahsa, 31982, Saudi Arabia.
Issa Al-HadaryAdministration of Pharmaceutical Care, Alahsa Health Cluster, Ministry of Health, Rashdiah Street, P. O. Box 12944, Alahsa, 31982, Saudi Arabia.
Naif AlhmeedNaif Alhmeed, Administration of Supply and Shared Services, Ministry of Health, Riyadh, Saudi Arabia.
Mossa AlismailPharmacy Department, King Faisal General Hospital, Alahsa, Saudi Arabia.
Ahmed H AlderaPharmacy Department, Prince Saud Bin Jalawi Hospital, Alahsa, Saudi Arabia.
Fadhil AlHbabiVirology Department, Regional Laboratory and Blood Bank, Riyadh, Saudi Arabia.
Haifa Al-ShammariDepartment of Histopathology, King Saud Medical City, Riyadh, Saudi Arabia.
Ali A RabaanMolecular Diagnostics Laboratory, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.
Awad Al-OmariCollege of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Ministry of Health · MMKing Faisal University · SAAlfaisal University · SAImam Mohammad ibn Saud Islamic University · SAKing Saud Medical City · SAMinistry of Health · SAPrince Mohammed bin Abdulaziz Hospital · SASaudi Aramco Medical Services Organization · SAUniversity of Jeddah · SAUniversity of Wollongong · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundStudying time-related changes in susceptible pathogens causing healthcare-associated infections (HAIs) is vital in improving local antimicrobial and infection control practices.

objectivesDescribe susceptibility patterns to several antimicrobials in gram-positive and gram-negative pathogens isolated from patients causing HAIs at three private tertiary care hospitals in Saudi Arabia over a 5-year period.

methodsData on trends of antimicrobial susceptibility among bacteria causing HAIs events in children and adults at three tertiary private hospitals located in Riyadh and Qassim, Saudi Arabia, were collected retrospectively between 2015 and 2019 using the surveillance data datasets.

resultsOver a 5-year period, 38,624 pathogens caused 17,539 HAI events in 17,566 patients. About 9450 (53.8%) of patients who suffered HAIs were females and the average age was 41.7 ± 14.3 years (78.1% were adults and 21.9% were children). Gram-negative pathogens were 2.3-times more likely to cause HAIs compared to gram-positive bacteria (71.9% vs. 28.1%). The ranking of causative pathogens in decreasing order was: Escherichia coli (38%), Klebsiella species (15.1%), and Staphylococcus aureus (12.6%). Gram-positive isolates were mostly susceptible to linezolid (91.8%) whereas they were resistant to ampicillin (52.6%), cefoxitin (54.2%), and doxycycline (55.9%). Gram-negative isolates were mostly sensitive to tigecycline (95%) whereas they were resistant to cefotaxime (49.5%) and cefixime (59.6%). During the 5 years, there were relatively stable susceptibility patterns to all tested antimicrobials, except for cefotaxime which shown a susceptibility reduction by 41.4%, among Escherichia coli and Klebsiella species. An increase in the susceptibility of Acinetobacter and Enterobacter and Citrobacter species to all studied antimicrobials was observed except for colistin that had a slight sensitivity reduction in 2019 by 4.3% against Acinetobacter species. However, we noted reduced sensitivity of MRSA, CoNS and Enterococcus species to gentamicin; and increased resistance of MRSA to linezolid and vancomycin.

conclusionThe observed increase in susceptibility of gram-positive and gram-negative bacteria to studied antimicrobials is important; however, reduced sensitivity of MRSA, CoNS and Enterococcus species to gentamicin; and increased resistance of MRSA to linezolid and vancomycin is a serious threat and calls for effective antimicrobial stewardship programs.

Indexed as

Delivery of Health CareHospitalsAdultAnti-Bacterial AgentsColistinCross InfectionDrug Resistance, Multiple, BacterialFemaleGram-Negative BacteriaGram-Positive BacteriaHumansLinezolidMaleMicrobial Sensitivity TestsMiddle AgedRetrospective StudiesAnti-Bacterial AgentsColistinLinezolidTigecyclineVancomycinAntibioticsAntimicrobialsGram-negativeGram-positiveHealthcare-associated infectionsRatesSaudi ArabiaSensitivitySusceptibility

Identifiers

PMID34118930
PMCPMC8196925
OpenAlexW3169097992

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.